Opportunity Information: Apply for PAR 21 242
This grant opportunity (PAR 21-242) is a National Institutes of Health (NIH) cooperative agreement using the U24 mechanism to support a Data Coordinating Center (DCC) for an investigator-initiated, multi-site clinical trial focused on mind and body interventions that align with the mission and priorities of the National Center for Complementary and Integrative Health (NCCIH). The core idea is that NCCIH is not looking for a stand-alone coordinating center in the abstract; it is specifically soliciting a DCC application that is paired with, and tailored to, a particular multi-site Phase III (and beyond) clinical trial application being submitted at the same time under the corresponding Clinical Coordinating Center (CCC) funding pathway (referenced as TEMP-12554). In practice, this means NCCIH will only consider the DCC if it is part of a matched set of applications: one application proposing the actual clinical trial operations (the CCC) and a second application proposing the coordinating and analytic backbone (the DCC), submitted simultaneously and designed to work together as a single integrated trial enterprise.
The purpose of the DCC is to lay out a full, trial-specific plan for overall coordination and for the technical infrastructure that makes a complex, multi-site trial credible and executable. NCCIH expects the DCC to cover project coordination and administration across participating sites, robust data management systems and workflows, and biostatistical leadership appropriate for a late-phase, multi-site clinical trial. While the FOA language stays high-level, the intent is clear: the DCC should be able to manage trial-wide data standards, quality control, database build and maintenance, data cleaning, audit trails, secure handling of sensitive information, and consistent procedures across sites. On the statistics side, the DCC is expected to support the trial with the design and analytic approach (including randomization schemes as appropriate), interim and final analyses as applicable, monitoring of data quality and performance metrics, and the kinds of reporting and documentation needed for a rigorous multi-site effort. Because this is a cooperative agreement, the award is structured for substantial NIH programmatic involvement compared with a standard research project grant, meaning applicants should anticipate active coordination expectations and ongoing interaction with NCCIH as the trial progresses.
Only trials that NCCIH deems both relevant to its mission and high program priority are intended to fall under this announcement. NCCIH emphasizes that applicants should consult the NCCIH website for its strategic vision and research priorities and, importantly, reach out to the appropriate NCCIH Scientific/Research contact before submission. That pre-submission contact is effectively a signal that fit and priority matter a lot here; applicants are being steered to confirm that the proposed mind and body intervention trial is within scope and competitive before investing in the paired CCC/DCC application package.
Eligibility is broad across U.S.-based organizations and governmental entities, reflecting NIH norms for clinical trial infrastructure. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other categories. The FOA also highlights additional eligible institution types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. At the same time, it draws firm boundaries around foreign participation: non-U.S. entities (foreign institutions) cannot apply as applicants, and non-U.S. components of U.S. organizations are not eligible to apply. However, foreign components as defined under the NIH Grants Policy Statement are allowed, which typically means a U.S. applicant organization can include certain foreign activities or collaborations if they meet NIH policy requirements and are well-justified, even though the applicant organization itself must be domestic.
Administrative details from the opportunity listing include that this is a discretionary funding opportunity; the funding instrument is a cooperative agreement; the activity category is health; and the CFDA number is 93.213. The opportunity was created on 2021-06-14, and the listed original closing date is 2024-03-11. Award ceiling and expected awards are not specified in the provided listing, which often means applicants need to consult the full FOA text and NCCIH guidance for budget expectations and the likely scale of support. Overall, the announcement is best read as NCCIH building a structured, two-part submission pathway for high-priority, late-phase, multi-site mind and body intervention trials: one application to run the trial and another, tightly linked application to ensure the data, coordination, and statistics are strong enough to support definitive, practice-informing conclusions.Apply for PAR 21 242
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
- This funding opportunity was created on 2021-06-14.
- Applicants must submit their applications by 2024-03-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: FY 2022 Clean Vessel Act (CVA)
Previous opportunity: Trinity River Restoration Program Watershed Grant Program Administration
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 21 242
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 21 242) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) Apply for PAR 21 241 Funding Number: PAR 21 241 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) Apply for RFA AG 22 017 Funding Number: RFA AG 22 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 018 Funding Number: RFA AG 22 018 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Disaster Risk Management Apply for 720 663 21 RFI 00007 Funding Number: 720 663 21 RFI 00007 Agency: Ethiopia USAID-Addis Ababa Category: Health Funding Amount: $8,000,000 |
| Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional) Apply for PAR 21 250 Funding Number: PAR 21 250 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed) Apply for PAR 21 249 Funding Number: PAR 21 249 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required) Apply for RFA MH 21 241 Funding Number: RFA MH 21 241 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) Apply for RFA DC 22 001 Funding Number: RFA DC 22 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01 Clinical Trial Not Allowed) Apply for PAR 21 269 Funding Number: PAR 21 269 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required) Apply for RFA MH 21 240 Funding Number: RFA MH 21 240 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) Apply for PAR 21 204 Funding Number: PAR 21 204 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional) Apply for RFA HG 21 025 Funding Number: RFA HG 21 025 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 22 027 Funding Number: RFA AG 22 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) Apply for RFA AG 22 022 Funding Number: RFA AG 22 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Apply for PAR 21 263 Funding Number: PAR 21 263 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for PAR 21 264 Funding Number: PAR 21 264 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) Apply for RFA HG 21 001 Funding Number: RFA HG 21 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) Apply for RFA HG 21 002 Funding Number: RFA HG 21 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18) Apply for PA 21 267 Funding Number: PA 21 267 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) Apply for PA 22 047 Funding Number: PA 22 047 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 242", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
